ClinicalTrials.Veeva

Menu
I

Institute for Respiratory Health | Perth , Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Axatilimab
RSP-1502
Bisoprolol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

A double-blind, active-controlled, multiple-ascending dose, safety study of aerosolized RSP-1502 in subjects with cystic fibrosis Pseudomonas aerugin...

Enrolling
Cystic Fibrosis Lung
Pseudomonas Aeruginosa
Drug: Tobramycin inhalation solution
Drug: RSP-1502

The study will evaluate the efficacy and safety of axatilimab in participants with IPF.

Enrolling
Idiopathic Pulmonary Fibrosis
Drug: Axatilimab
Other: Placebo

Trial sponsors

R
Syndax Pharmaceuticals logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems